BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16625791)

  • 1. Effect of screening result on waiting times to assessment and breast cancer diagnosis: results from the Ontario Breast Screening Program.
    Chiarelli AM; Mai V; Halapy EE; Shumak RS; O'Malley FP; Klar NS
    Can J Public Health; 2005; 96(4):259-63. PubMed ID: 16625791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care.
    Chiarelli AM; Muradali D; Blackmore KM; Smith CR; Mirea L; Majpruz V; O'Malley FP; Quan ML; Holloway CM
    Br J Cancer; 2017 May; 116(10):1254-1263. PubMed ID: 28359079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the influence of clinical breast examination reports on the interpretation of mammograms in a breast screening program. Ontario Breast Screening Program Radiologists Research Group.
    Knight JA; Libstug AR; Moravan V; Boyd NF
    Breast Cancer Res Treat; 1998 Mar; 48(1):65-71. PubMed ID: 9541190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
    Eisen A; Blackmore KM; Meschino WS; Muradali D; Carroll JC; Majpruz V; Warner E; Rabeneck L; Chiarelli AM
    Mol Genet Genomic Med; 2018 Mar; 6(2):213-223. PubMed ID: 29368425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000.
    Chiarelli AM; Halapy E; Nadalin V; Shumak R; O'Malley F; Mai V
    Eur J Cancer Prev; 2006 Feb; 15(1):34-42. PubMed ID: 16374227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitated "fast track" referral reduces time from abnormal screening mammogram to diagnosis.
    Borugian MJ; Kan L; Chu CC; Ceballos K; Gelmon KA; Gordon PB; Poole B; Tyldesley S; Olivotto IA
    Can J Public Health; 2008; 99(4):252-6. PubMed ID: 18767265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short report: Limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia.
    Kardinah D; Anderson BO; Duggan C; Ali IA; Thomas DB
    Int J Cancer; 2014 Mar; 134(5):1250-5. PubMed ID: 24037942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces.
    Olivotto IA; Bancej C; Goel V; Snider J; McAuley RG; Irvine B; Kan L; Mirsky D; Sabine MJ; McGilly R; Caines JS
    CMAJ; 2001 Aug; 165(3):277-83. PubMed ID: 11517642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of organized breast assessment on survival by stage for screened women diagnosed with invasive breast cancer.
    Smith CR; Chiarelli AM; Holloway CM; Mirea L; O'Malley FP; Blackmore KM; Pandya A; Majpruz V; Harris CP; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D
    Breast; 2018 Oct; 41():25-33. PubMed ID: 29957557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary node dissection in patients with breast cancer diagnosed through the Ontario Breast Screening Program: a need for minimally invasive techniques.
    Singhal H; O'Malley FP; Tweedie E; Stitt L; Tonkin KS
    Can J Surg; 1997 Oct; 40(5):377-82. PubMed ID: 9336528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of clinical breast examination to mammography screening in the early detection of breast cancer.
    Bancej C; Decker K; Chiarelli A; Harrison M; Turner D; Brisson J
    J Med Screen; 2003; 10(1):16-21. PubMed ID: 12790311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive result and reattendance in the Ontario Breast Screening Program.
    Chiarelli AM; Moravan V; Halapy E; Majpruz V; Mai V; Tatla RK
    J Med Screen; 2003; 10(3):129-33. PubMed ID: 14561264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
    Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
    J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of wait times across the breast cancer treatment pathway among screened women undergoing organized breast assessment versus usual care.
    Blackmore KM; Weerasinghe A; Holloway CMB; Majpruz V; Mirea L; O'Malley FP; Paroschy Harris C; Hendry A; Hey A; Kornecki A; Lougheed G; Maier BA; Marchand P; McCready D; Rand C; Raphael S; Segal-Nadler R; Sehgal N; Muradali D; Chiarelli AM
    Can J Public Health; 2019 Oct; 110(5):595-605. PubMed ID: 31037608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical breast examination for screening of asymptomatic women: the importance of clinical breast examination for breast cancer detection.
    Park BW; Kim SI; Kim MH; Kim EK; Park SH; Lee KS
    Yonsei Med J; 2000 Jun; 41(3):312-8. PubMed ID: 10957884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The abnormal mammogram in women with clinically normal breasts.
    Sterns EE
    Can J Surg; 1995 Apr; 38(2):168-72. PubMed ID: 7728672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organized breast screening improves reattendance compared to physician referral: a case control study.
    Makedonov I; Gu S; Paszat LF;
    BMC Cancer; 2015 Apr; 15():315. PubMed ID: 25928416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incremental contribution of clinical breast examination to invasive cancer detection in a mammography screening program.
    Oestreicher N; Lehman CD; Seger DJ; Buist DS; White E
    AJR Am J Roentgenol; 2005 Feb; 184(2):428-32. PubMed ID: 15671358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waiting for a diagnosis after an abnormal screening mammogram. SMPBC diagnostic process workgroup. Screening Mammography Program of British Columbia.
    Olivotto IA; Kan L; King S
    Can J Public Health; 2000; 91(2):113-7. PubMed ID: 10832174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.